Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.8M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$60.5M |
| 3 |
Merck
MRK
|
+$50.9M |
| 4 |
Pinduoduo
PDD
|
+$40.5M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$36.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$162M |
| 2 |
Meta Platforms (Facebook)
META
|
+$115M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$82.8M |
| 4 |
iShares Gold Trust
IAU
|
+$66M |
| 5 |
Johnson & Johnson
JNJ
|
+$65.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.63% |
| 2 | Healthcare | 21.92% |
| 3 | Consumer Discretionary | 11.78% |
| 4 | Financials | 5.4% |
| 5 | Communication Services | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Texas Instruments
TXN
$261B
| $5.26M | 0.03% |
+29,236
| New | +$5.03M |
|
|
THS
302
DELISTED
Treehouse Foods
THS
| $5.24M | 0.03% |
104,007
-5,427
| -5% | -$278K |
|
303
Valero Energy
VLO
$85.9B
| $5.21M | 0.03% |
44,457
+13,731
| +45% | +$1.6M |
|
304
Neurocrine Biosciences
NBIX
$16.6B
| $5.2M | 0.03% |
55,165
-4,045
| -7% | -$395K |
|
305
NRG Energy
NRG
$24.8B
| $5.2M | 0.03% |
139,061
-365
| -0.3% | -$12.4K |
|
|
SWN
306
DELISTED
Southwestern Energy Company
SWN
| $5.2M | 0.03% |
864,585
+168,964
| +24% | +$871K |
|
307
Everest Group
EG
$14.4B
| $5.18M | 0.03% |
15,160
-63
| -0.4% | -$22.8K |
|
308
Qfin Holdings
QFIN
$1.61B
| $5.09M | 0.03% |
294,464
-895,864
| -75% | -$15.1M |
|
309
Globus Medical
GMED
$11.2B
| $5.08M | 0.03% |
85,311
-8,839
| -9% | -$504K |
|
310
Helen of Troy
HELE
$693M
| $5.03M | 0.03% |
46,577
-55,273
| -54% | -$5.29M |
|
311
Nike
NKE
$61.9B
| $4.98M | 0.03% |
+45,133
| New | +$5.28M |
|
312
WD-40
WDFC
$3.15B
| $4.94M | 0.03% |
26,176
-1,709
| -6% | -$323K |
|
313
Affiliated Managers Group
AMG
$9.76B
| $4.93M | 0.03% |
32,895
-95
| -0.3% | -$13.6K |
|
314
Neogen
NEOG
$2.5B
| $4.88M | 0.03% |
224,367
-8,908
| -4% | -$161K |
|
315
Huntsman Corp
HUN
$1.77B
| $4.86M | 0.03% |
179,979
-1,508
| -0.8% | -$39.2K |
|
316
Interparfums
IPAR
$3.94B
| $4.79M | 0.03% |
35,394
-2,410
| -6% | -$338K |
|
317
NovoCure
NVCR
$1.91B
| $4.78M | 0.03% |
115,226
-12,518
| -10% | -$777K |
|
318
DXC Technology
DXC
$1.73B
| $4.72M | 0.03% |
176,798
+79,614
| +82% | +$1.98M |
|
319
Union Pacific
UNP
$174B
| $4.7M | 0.03% |
22,972
-9,889
| -30% | -$1.97M |
|
320
Haemonetics
HAE
$4B
| $4.7M | 0.03% |
55,195
-6,434
| -10% | -$544K |
|
321
Olin
OLN
$2.12B
| $4.64M | 0.03% |
90,203
+39,548
| +78% | +$2.1M |
|
322
O'Reilly Automotive
ORLY
$76.3B
| $4.6M | 0.03% |
72,180
-134,610
| -65% | -$8.22M |
|
323
Etsy
ETSY
$7.85B
| $4.58M | 0.03% |
54,189
+49,013
| +947% | +$4.62M |
|
324
Autohome
ATHM
$2.62B
| $4.54M | 0.03% |
155,788
+35,128
| +29% | +$1.05M |
|
325
Rio Tinto
RIO
$164B
| $4.53M | 0.03% |
70,975
+9,549
| +16% | +$614K |
|
Similar funds
Ray Dalio's Q2 2023 Portfolio in Review
As of Q2 2023, Ray Dalio held 787 positions worth $16.2B, down 1.2% from $16.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ray Dalio withdrew a net $701M in Q2 2023, closing 91 positions and reducing 342 holdings. Its most notable exit was SPDR Gold Trust, an estimated $162M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ray Dalio opened a new position in AT&T worth $31.6M.
- Ray Dalio's largest Q2 2023 buy was AT&T: 1,982,375 shares worth $31.6M.
- Ray Dalio added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $77.8M increase.
- Ray Dalio's biggest Q2 2023 reduction was Meta Platforms (Facebook), cutting an estimated $115M.
- Ray Dalio fully exited SPDR Gold Trust in Q2 2023, selling an estimated $162M.
- Ray Dalio's ten largest holdings make up 35% of its $16.2B portfolio in Q2 2023.
- Ray Dalio opened 77 new positions and closed 91 in Q2 2023.
- Ray Dalio's portfolio value fell 1.2% quarter-over-quarter to $16.2B.
Based on Bridgewater Associates's 13F filing for Q2 2023, filed 11 Aug 2023.